226 filings
Page 4 of 12
8-K
4eww9ftc85kb xvn
31 Mar 23
Motus GI Reports Fourth Quarter and Full Year 2022 Financial Results
4:05pm
8-K
f51gk8dn25a5u uy4
14 Mar 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
9:00am
8-K
itbdf5ftx c3r99x1c
10 Jan 23
Motus GI Announces Exploration of Strategic Alternatives to Enhance Shareholder Value
8:40am
8-K
d3jhgc11 rm16oyoqm
21 Dec 22
Motus GI Announces Improvement of Pure-Vu® EVS System for Use in Upper Gastrointestinal (GI) Bleeding Procedures Following Successful Pre-Clinical Tests
8:12am
8-K
e8rxl lowcvd
14 Nov 22
Motus GI Reports Third Quarter 2022 Financial Results
4:14pm
8-K
0acbym
24 Oct 22
Motus GI Announces Positive Clinical Data for Pure-Vu EVS in Three Poster
8:40am
8-K
x86sgdh awb2jxwwcg
6 Oct 22
Motus GI Granted a U.S. Patent for Prepless Colonoscopy Methods
9:15am
8-K
c526z8fgaqa yf
29 Sep 22
Regulation FD Disclosure
9:15am
8-K
okqkew ygri4oc4bb44p
24 Aug 22
Amendments to Articles of Incorporation or Bylaws
5:00pm
8-K
2s5xeym 05fwg
11 Aug 22
Motus GI Reports Second Quarter 2022 Financial Results
4:10pm
8-K
at9mnrj
11 Aug 22
Other Events
8:05am
8-K
7py7re 5fv35n3an88ka
26 Jul 22
Material Modifications to Rights of Security Holders
9:00am
8-K
e8o0tzob
30 Jun 22
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
lrwlf20zuen4d554h
24 May 22
Motus GI Announces Positive Topline Data From EU Study of the Pure-Vu System
4:10pm
DEFA14A
nh95uk0ydyaxlniac xp
23 May 22
Additional proxy soliciting materials
4:30pm
8-K
tx8gbxm67rf1fsekhqfe
12 May 22
Motus GI Reports First Quarter 2022 Financial Results
4:10pm